secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001104659-24-071735
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax stockholders approve director elections, advisory pay, and equity plan share increases
--------------------------------------------------------------------------------

- Stockholders elected Class II directors Richard Douglas, Margaret McGlynn, and David Mott with majorities (approx. 25.5M, 22.9M, 23.1M For).
- Advisory vote on 2023 executive compensation passed: 24.2M For, 8.7M Against, 11.0M Abstain.
- Amended 2015 Stock Incentive Plan approved (22.4M For, 20.9M Against), adding 6.5M shares to the pool.
- Amended 2013 Employee Stock Purchase Plan approved (23.2M For, 10.0M Abstain), adding 1M shares with annual increase formula.
- Ratification of Ernst & Young as auditor for FY2024 passed overwhelmingly (69.0M For).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924071735/0001104659-24-071735-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924071735/tm2417354d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-071735

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer